Ute Modlich

5.8k citations

78 papers · 3.7k indexed · h-index 28

Impact in

Genetics top 0.5%
- Virus-based gene therapy research
Molecular Biology top 2%
- CRISPR and Genetic Engineering
- RNA Interference and Gene Delivery
- Viral Infectious Diseases and Gene Expression in Insects
- Pluripotent Stem Cells Research
- Angiogenesis and VEGF in Cancer

Papers in ⓘ

Genetics 52
- Virus-based gene therapy research 51
Hematology 15
- Platelet Disorders and Treatments 10
- Acute Myeloid Leukemia Research 5
- Hematopoietic Stem Cell Transplantation 5

Co-authors: Christopher Baum (24 shared papers)Axel Schambach (31 shared papers)Boris Fehse (8 shared papers)Olga Kustikova (8 shared papers)Tobias Maetzig (8 shared papers)Hellmut G. Augustin (2 shared papers)Zhixiong Li (3 shared papers)Martijn H. Brugman (10 shared papers)
Journals: Molecular Therapy (10 papers)Blood (10 papers)Gene Therapy (7 papers)Human Gene Therapy (5 papers)Molecular Therapy — Nucleic Acids (4 papers)
Partner nations: Germany United States Netherlands

In The Last Decade

Ute Modlich

78 papers receiving 3.7k citations

Peers

Countries citing papers authored by Ute Modlich

Since Specialization

Citations

This map shows the geographic impact of Ute Modlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Modlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Modlich more than expected).

Fields of papers citing papers by Ute Modlich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ute Modlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Modlich. The network helps show where Ute Modlich may publish in the future.

Co-authors

The 25 scholars most cited alongside Ute Modlich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ute Modlich Line = papers co-authored together Ute Modlich links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mutagenesis and Oncogenesis by Chromosomal Insertion of Gene Transfer Vectors Human Gene Therapy ·Christopher Baum, Olga Kustikova, Ute Modlich, Zhixiong Li, Boris Fehse	2006	292
2	Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors Molecular Therapy ·Ute Modlich, Susana Navarro, Daniela Zychlinski, Tobias Maetzig, Sabine Knoess, Martijn H. Brugman, Axel Schambach, Sabine Charrier, Anne Galy, Adrian J. Thrasher, Juan A. Bueren, Christopher Baum	2009	289
3	Clonal Dominance of Hematopoietic Stem Cells Triggered by Retroviral Gene Marking Science ·Olga Kustikova, Boris Fehse, Ute Modlich, Min Yang, J. Düllmann, Kenji Kamino, Nils von Neuhoff, Brigitte Schlegelberger, Zhixiong Li, Christopher Baum	2005	274
4	Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity Blood ·Ute Modlich, Jens Bohne, Manfred Schmidt, Christof von Kalle, Sabine Knöß, Axel Schambach, Christopher Baum	2006	254
5	Delta4, an endothelial specific Notch ligand expressed at sites of physiological and tumor angiogenesis Differentiation ·Carolina Mailhos, Ute Modlich, Julian Lewis, Adrian L. Harris, Roy Bicknell, David Ish‐Horowicz	2001	233
6	Physiological Promoters Reduce the Genotoxic Risk of Integrating Gene Vectors Molecular Therapy ·Daniela Zychlinski, Axel Schambach, Ute Modlich, Tobias Maetzig, Johann Meyer, Elke Grassman, Anjali Mishra, Christopher Baum	2008	215
7	Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. PubMed ·Hellmut G. Augustin, Kathleen R. Braun, I Telemenakis, Ute Modlich, Walter Kühn	1995	162
8	Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis Blood ·Ute Modlich	2005	156
9	In vivo generation of human CD 19‐ CAR T cells results in B‐cell depletion and signs of cytokine release syndrome EMBO Molecular Medicine ·Anett Pfeiffer, Frederic B. Thalheimer, Sylvia Hartmann, Annika M. Frank, R. Bender, Simon Danisch, Caroline Costa, Winfried S. Wels, Ute Modlich, Renata Stripecke, Els Verhoeyen, Christian J. Buchholz	2018	142
10	Cyclic angiogenesis and blood vessel regression in the ovary: blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion. PubMed ·Ute Modlich, F.‐J. Kaup, Hellmut G. Augustin	1996	114
11	Biosafety Challenges for Use of Lentiviral Vectors in Gene Therapy Current Gene Therapy ·Michael Rothe, Ute Modlich, Axel Schambach	2014	92
12	Lentiviral vectors pseudotyped with murine ecotropic envelope: Increased biosafety and convenience in preclinical research Experimental Hematology ·Axel Schambach, Melanie Galla, Ute Modlich, Elke Will, Saurabh Chandra, Lilith Reeves, Melissa C. Colbert, David A. Williams, Christof von Kalle, Christopher Baum	2006	90
13	High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia Frontiers in Immunology ·Stephan Müller, Tobias Bexte, Veronika Gebel, Franziska Kalensee, Eva Stolzenberg, Jessica Hartmann, Ulrike Koehl, Axel Schambach, Winfried S. Wels, Ute Modlich, Evelyn Ullrich	2020	90
14	Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16 Leukemia ·Ute Modlich, Axel Schambach, Martijn H. Brugman, Daniel C. Wicke, Sabine Knoess, Z Li, Tobias Maetzig, Cornelia Rudolph, Brigitte Schlegelberger, Christel Baum	2008	78
15	Retroviral vector insertion sites associated with dominant hematopoietic clones mark “stemness” pathways Blood ·Olga Kustikova, Hartmut Geiger, Zhixiong Li, Martijn H. Brugman, Stuart M. Chambers, Chad A. Shaw, Karin Pike‐Overzet, Dick de Ridder, Frank J. T. Staal, Gottfried von Keudell, Kerstin Cornils, Kalpana Nattamai, Ute Modlich, Gerard Wagemaker, Margaret A. Goodell, Boris Fehse, Christopher Baum	2006	76
16	Self-inactivating retroviral vectors with improved RNA processing Gene Therapy ·Janine Kraunus, DHS Schaumann, Johann Meyer, Ute Modlich, Boris Fehse, Gunda Brandenburg, Dorotheé von Laer, Hannes Klump, Axel Schambach, Jens Bohne, Christel Baum	2004	71
17	HOXB4 enforces equivalent fates of ES-cell-derived and adult hematopoietic cells Proceedings of the National Academy of Sciences ·Sandra Pilat, Sebastian Carotta, Bernhard Schiedlmeier, Kenji Kamino, Andreas Mairhofer, Elke Will, Ute Modlich, Peter Steinlein, Wolfram Ostertag, Christopher Baum, Hartmut Beug, Hannes Klump	2005	65
18	Genotoxic Potential of Lineage-specific Lentivirus Vectors Carrying the β-Globin Locus Control Region Molecular Therapy ·Paritha Arumugam, Tomoyasu Higashimoto, Fabrizia Urbinati, Ute Modlich, Shawna Nestheide, Ping Xia, Catherine Fox, Andrea Corsinotti, Christopher Baum, Punam Malik	2009	61
19	Predictable and efficient retroviral gene transfer into murine bone marrow repopulating cells using a defined vector dose Experimental Hematology ·Zhixiong Li, Maike Schwieger, Claudia Lange, Janine Kraunus, Sun Hanying, Eric van den Akker, Ute Modlich, Ebru Serinsöz, Elke Will, Dorotheé von Laer, Carol Stocking, Boris Fehse, Bernd Schiedlmeier, Christopher Baum	2003	61
20	Alpharetroviral Self-inactivating Vectors: Long-term Transgene Expression in Murine Hematopoietic Cells and Low Genotoxicity Molecular Therapy ·Julia D. Suerth, Tobias Maetzig, Martijn H. Brugman, Niels Heinz, Jens-Uwe Appelt, Kerstin B. Kaufmann, Manfred Schmidt, Manuel Grez, Ute Modlich, Christopher Baum, Axel Schambach	2012	60

About Ute Modlich

Ute Modlich is a scholar working on Genetics, Hematology, Molecular Biology, Immunology and Oncology, having authored 78 papers that have together received 3.7k indexed citations. Recurring topics across this work include Virus-based gene therapy research (51 papers), CRISPR and Genetic Engineering (33 papers), RNA Interference and Gene Delivery (21 papers), CAR-T cell therapy research (15 papers), Platelet Disorders and Treatments (10 papers), Viral Infectious Diseases and Gene Expression in Insects (10 papers), Acute Myeloid Leukemia Research (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). The work is most often cited by research in Genetics (2.1k citations), Molecular Biology (2.8k citations), Oncology (1.1k citations), Hematology (292 citations) and Immunology (454 citations). Ute Modlich has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Christopher Baum, Axel Schambach, Boris Fehse, Olga Kustikova, Tobias Maetzig, Hellmut G. Augustin, Zhixiong Li, Martijn H. Brugman, Daniela Zychlinski and Roy Bicknell. Their work appears in journals such as Molecular Therapy, Blood, Gene Therapy, Human Gene Therapy and Molecular Therapy — Nucleic Acids.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact